WARNER CHILCOTT PLC | 15,538 Euro | -0,103 -0,66 % | |
| WKN: A0YALR ISIN: IE00B446CM77 Ticker-Symbol: G3LA | Frankfurt | 23.05.13 | 08:38 Uhr |
Branche PharmaAktienmarkt NASDAQ Biotech |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 22.05. | The Zacks Analyst Blog Highlights: Actavis, Warner Chilcott, Bill Barrett, Linn Energy and Forest Oil | 50 | PR Newswire | |
| CHICAGO, May 22, 2013 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting... Mehr lesen zu: The Zacks Analyst Blog Highlights: Actavis, Warner Chilcott, Bill Barrett, Linn Energy and Forest Oil | ||||
| 22.05. | Actavis to purchase Warner Chilcott in US$8.5 bil. deal | 6 | China Post | |
| 21.05. | Actavis to Buy Warner Chilcott | 1 | Zacks | |
| 21.05. | Moody's reviews Warner Chilcott for upgrade | 3 | StockMarketWire | |
| 21.05. | Downgrade Alert for Warner Chilcott | 3 | SmarTrend | |
| 21.05. | Actavis to buy Warner Chilcott in $5 billion stock deal | 1 | Irish Times | |
| 21.05. | Deutsche Bank AG: Form 38.5 Warner Chilcott Plc | 6 | InvestEgate | |
| 21.05. | Actavis- und Warner Chilcott-Aktien profitieren von Fusionsplänen | 85 | aktiencheck.de | |
| Parsippany - Der US-Generikahersteller Actavis (ISIN US00507K1034/ WKN A1JAK0) will den irischen Konkurrenten Warner Chilcott (ISIN IE00B446CM77/ WKN A0YALR) für 8,5 Mrd. USD übernehmen. Die Anteilseigner... Mehr lesen zu: Actavis- und Warner Chilcott-Aktien profitieren von Fusionsplänen | ||||
| 21.05. | Generikahersteller Actavis kauft Warner Chilcott in Milliardendeal | 353 | Dow Jones News | |
| Von Peter Loftus
Der Pharmabranche steht eine milliardenschwere Übernahme ins Haus. Der Generikahersteller Actavis kauft für rund 5 Milliarden US-Dollar in Aktien seinen irischen Wettbewerber... Mehr lesen zu: Generikahersteller Actavis kauft Warner Chilcott in Milliardendeal | ||||
| 21.05. | Actavis to buy contraceptive maker Warner Chilcott in $5bn stock deal | 3 | Irish Independent | |
| 21.05. | Actavis Lowers Tax Rate to 17% After Warner Chilcott Deal | - | Bloomberg | |
| 21.05. | Actavis to buy Warner Chilcott in US$5bil stock deal | - | The Star | |
| 20.05. | Warner Chilcott plc - 8-K, Current Report | 3 | SEC Filings | |
| 20.05. | Actavis, Inc., Warner Chilcott plc - M&A Call | 3 | Seeking Alpha | |
| 20.05. | Actavis to buy rival Warner Chilcott | 3 | UPI.com | |
| 20.05. | Activis to buy rival Warner Chilcott | 1 | UPI.com | |
| 20.05. | 3rd UPDATE: Actavis to Buy Warner Chilcott for $5 Billion in Stock | 1 | Euroinvestor | |
| 20.05. | News Summary: Actavis plans Warner Chilcott deal | 1 | Yahoo-USA | |
| 20.05. | Actavis will Warner Chilcott für 8,5 Milliarden US-Dollar kaufen | 9 | boerse-express.com | |
| 20.05. | Pharma M&A – Actavis to Acquire Warner Chilcott | 4 | Benzinga.com | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| STADA ARZNEIMITTEL | 33,92 | -0,53 % | Stada: Deutsche Bank zeigt Interesse |
| CELESIO | 16,13 | -3,79 % | XFRA DIVIDEND INFORMATION - 17.05.2013 - 1 |
| NOVO NORDISK | 130,90 | -1,98 % | Novo Nordisk and Paula Deen Announce Winners of the Seeing Diabetes in a New Light' Contest |
| GILEAD SCIENCES | 42,39 | -3,00 % | Maximieren Sie Ihren Ertrag in nur 30 Minuten! (Freenet +370% / Technotrans +100% / Gilead +120% ...) |
| ABBOTT LABORATORIES | 28,867 | -3,58 % | Goldman Sachs stuft Abbott Labs von Neutral auf Buy hoch |
